2d
Zacks Small Cap Research on MSNIMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer…IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On ...
Gyre Therapeutics (GYRE) announced the publication of the manuscript titled “Hydronidone for the Treatment of Liver Fibrosis Associated with ...
Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
Imunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.
The digitization of clinical trial protocols marks a fundamental shift away from traditional manual processes, reducing variability and errors. AI-driven tools now streamline protocol creation, which ...
This protocol describes a novel method for comparing indicators with research evidence in clinical trials, and will help to determine if indicators associated with the management of asthma in children ...
A literature search of the following electronic databases will be carried out: PubMed, PsycINFO, WOS, Scopus and Cochrane Central Register of Controlled Trials. Search will be supplemented by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results